Showing 2754 results
-
Event /At this year’s European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Annual Meeting, we will be sharing the latest data and research from our neuroscience portfolio, driven by…
-
Press release /ARTIOS Phase IIIb, open-label, single-arm, prospective study showed a substantial reduction in disease activity in people with relapsing multiple sclerosis (RMS) following switch to Kesimpta after…